Genotype and malocclusion in patients with osteogenesis imperfecta

被引:10
|
作者
Jabbour, Z. [1 ]
Al-Khateeb, A. [1 ]
Eimar, H. [1 ]
Retrouvey, J. M. [1 ]
Rizkallah, J. [2 ]
Glorieux, F. H. [3 ]
Rauch, F. [3 ]
Tamimi, F. [1 ]
机构
[1] McGill Univ, Fac Dent, Montreal, PQ, Canada
[2] Montreal Childrens Hosp, Montreal, PQ, Canada
[3] Shriners Hosp Children, Montreal, PQ, Canada
关键词
brittle bone disease; COL1A1; COL1A2; collagen; dental occlusion; mutation; MUTATIONS; CHILDREN;
D O I
10.1111/ocr.12218
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectsTo investigate the relationship between genotype and severity of malocclusion in osteogenesis imperfecta (OI). Setting and Sample PopulationA total of 49 patients participated in this cross-sectional study (age range: 5-19years; 28 females; diagnoses: OI type I, N=7; OI type III, N=11; OI type IV, N=27; OI type V, N=2; OI type VI, N=2). Materials and MethodsSequence analysis of COL1A1/COL1A2 and other OI-related genes was compared to the Peer Assessment Rating (PAR), an index reflecting the severity of malocclusion. ResultsThe mutation spectrum was as follows: COL1A1, N=22; COL1A2, N=22, IFITM5, N=2; SERPINF1, N=2; no mutation detected, N=1). Compared to patients with COL1A1 mutations, patients with COL1A2 mutations had significantly higher scores for total PAR, anterior cross-bite, anterior open bite and anteroposterior buccal occlusion. Males with COL1A2 mutations had significantly higher total PAR scores than females (median 36 vs 30, P=.047, Mann-Whitney test). Exploratory correlation between age and buccal vertical occlusion was noted in patients with COL1A2 mutations (Spearman correlation: r=.46, P=.03, power=.50). Two patients with OI type V (caused by IFITM5 mutations) had total PAR scores of 44 and 21. Both patients scored high for segment. Patients with OI type VI (due to SERPINF1 mutations) scored similar to OI type V for centreline. Considerable difference was observed in the total PAR score between the 2 patients with OI type VI. They had total PAR of 43 and 2. ConclusionType of disease-causing mutation affects the severity of malocclusion in individuals with OI.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [41] Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
    Choi, Yunha
    Hwang, Soojin
    Kim, Gu-Hwan
    Lee, Beom Hee
    Yoo, Han-Wook
    Choi, Jin-Ho
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (01) : 22 - 29
  • [42] Bisphosphonate therapy for osteogenesis imperfecta
    Dwan, Kerry
    Phillipi, Carrie A.
    Steiner, Robert D.
    Basel, Donald
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10):
  • [43] Osteogenesis imperfecta
    Salzmann, M.
    Krohn, C.
    Berger, N.
    ORTHOPADE, 2014, 43 (08): : 764 - 771
  • [44] Osteogenesis imperfecta - A clinical update
    Tournis, Symeon
    Dede, Anastasia D.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 80 : 27 - 37
  • [45] Skeletal Manifestations of Osteogenesis Imperfecta
    Fotiadou, Anastasia N.
    Calleja, Michele
    Hargunani, Rikin
    Keen, Richard
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2016, 20 (03) : 279 - 286
  • [46] Molecular Mechanisms of Osteogenesis Imperfecta
    Lu Yan-Qin
    Ren Xiu-Zhi
    Wang Yan-Zhou
    Han Jin-Xiang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (06) : 511 - 518
  • [47] Bisphosphonate therapy for osteogenesis imperfecta
    Dwan, Kerry
    Phillipi, Carrie A.
    Steiner, Robert D.
    Basel, Donald
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [48] Osteogenesis imperfecta
    Chan, E.
    DeVile, C.
    Ratnamma, V. S.
    BJA EDUCATION, 2023, 23 (05) : 182 - 188
  • [49] Osteogenesis imperfecta
    Salzmann, M.
    Krohn, C.
    Berger, N.
    ORTHOPADE, 2014, 43 (08): : 764 - 771
  • [50] Osteogenesis imperfecta
    Natarajan, Surya Besant
    Baalann, Krishna Prasanth
    PAN AFRICAN MEDICAL JOURNAL, 2021, 40